Very high molecular weight β-glucans
The invention pertains to compositions and therapeutic and prophylatic methods for treating/preventing infections in an animal or human by administering a soluble β-glucan composition comprising β-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering (VHMW-glucan).
1. A method for enhancing myclopoeisis and thrombopoeisis comprising administering to an animal or human the aqueous soluble underivatized, β-glucan composition comprising β-glucan molecules having an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering, wherein the composition has a triple helix aggregate conformation and enhances immune response without inducing TNF-α, IL-1β and IL-6, in an amount sufficient for enhancing myelopoeisis and thrombopoeisis.
2. An aqueous soluble β-glucan composition comprising β-glucan molecules having a molecular weight of about 2,000,000 daltons to about 4,000,000 daltons as determined by a multi-angle laser light scattering, wherein the composition has a triple helix aggregate conformation and enhances immune response without stimulating production of biochemical mediators that induce detrimental side effects.
3. A method of inducing an immune response in an animal or human comprising administering to the animal or human the aqueous soluble underivatized, β-glucan composition of claim 2 , in an amount sufficient for inducing an immune response.
4. A method for treating infection in an animal or human, comprising administering to the animal or human the aqueous soluble underivatized, β-glucan composition of claim 2 , in an amount sufficient to treat infection.
5. A method for stimulating repair and healing of a wound site on an animal or human comprising administering to the wound site the aqueous soluble underivatized, β-glucan composition of claim 2 , in an amount sufficient for stimulating repair and healing of a wound site.
6. A method for stimulating wound healing and treating infections associated with the wound, comprising administering to the wound site the aqueous soluble underivatized β-glucan composition of claim 2 , in an amount sufficient for stimulating wound healing and treatment of wound infection.
7. A method for enhancing the microbicidal activity of phagocytic cells comprising administering to a animal or human the aqueous soluble underivatized, β-glucan composition of claim 2 , in an amount sufficient for enhancing the microbicidal activity of phagocytic cells.
8. A method for stimulating hematopoiesis comprising administering to an animal or human the aqueous soluble underivatized, β-glucan composition of claim 2 , in an amount sufficient for stimulating hematopoiesis.
9. A method for treating refractory infections comprising administering to an animal or human the aqueous soluble underivatized, β-glucan composition of claim 2 , in an amount sufficient for treating refractory infections.
10. A method for stimulating the production of platelet in an animal or human, comprising administering to the animal or human the aqueous soluble underivatized, β-glucan composition of claim 2 , in an amount sufficient for stimulating the production of platelet.
11. A method for therapeutically treating an animal or human having an established infection, comprising administering to the animal or human the aqueous soluble underivatized β-glucan compositions of claim 2 , in an amount sufficient for treating the infection.
12. A method of accelerating bacterial clearance in an animal or human having an established infection comprising administering to the animal or human the aqueous soluble underivatized β-glucan compositions of claim 2 , in an amount sufficient for accelerating bacterial clearance.